Fertility Test Market

Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood)), Mode of Purchase (OTC, Prescription, Online), Application (Female, Male), End User (Home care, Fertility clinics, hospitals) - Global Forecast to 2025

Report Code: MD 4215 Apr, 2021, by marketsandmarkets.com

[183 Pages Report] The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5 %  the forecast period. Growth in this market is primarily driven by by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed as well as developing countries.

Fertility Test Market

To know about the assumptions considered for the study, download the pdf brochure

COVID-19 Impact on the global Fertility Test Market

The COVID-19 pandemic has emerged as a huge challenge for the global fertility market. In the initial stages of the pandemic, authorities recommended the suspension of all in-person fertility treatments. For instance, in March 2020, the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society announced their recommendations to instantly and for the foreseeable future suspend all in-person fertility treatments in the US and Canada due to COVID-19.

One in six reproductive-aged couples experiences infertility, and many turn to treatments such as IUI and IVF, which require several in-person appointments to complete. Around 3 million people seek infertility treatment in India every year, but only 0.5 million people undergo IVF/Intrauterine Insemination (IUI) procedure. As per data, of the 1,100 centers across India, an ~90% drop was observed in the number of people undergoing IVF cycles between April and June 2020. This data is indicative of the cancellation of IVF cycles among several couples. Due to this situation, people have turned to alternative testing and planning methods like fertility monitors and ovulation prediction kits. The wide availability of fertility testing devices, ovulation devices, and fertility monitors on e-commerce websites has increased the consumption of these devices among people monitoring their reproductive health during the pandemic.

The impact of COVID-19 on the male fertility market can be considered to be positive. The SARS-CoV-2 main complementary protein and mediator for SARS-CoV-2 have been identified to be the angiotensin-converting enzyme 2 (ACE2) that exists in various organs and is highly expressed within the testicular tissue (spermatogonia, Leydig, and Sertoli cells). According to the WHO, the male reproductive system should be considered a vulnerable route of COVID-19 infection and declared a high-risk organ. ROS accumulation, complex protein formation, and renin system failure could also progress to intercellular edema, which could lead to intratesticular obstruction with consequences such as sperm count reduction and elevated Sperm DNA Fragmentation Index (SDFI). Testicular ultrasonography, semen analysis, and male hormone profiling are recommended after a person has been affected by COVID-19. Owing to this, the male fertility market showcased an upsurge in demand for testing products and thus gained market share during the pandemic.

Fertility Test Market Dynamics

Driver: Increasing first-time pregnancy age

Over the last few decades, the average age of first-time pregnancy has increased drastically across the globe owing to the decline in first births among teenage women and the increase of first births among women aged over 30 years. According to the OECD, the average age at which women give birth now stands at 30 or above; this trend is majorly being observed as women across the globe are showcasing a greater preference for postponing first-time pregnancies.

Listed below are some significant products launched in recent years:

  • According to the OECD Family Database, the average mean age of first-time pregnancy across OECD-25 countries has increased from 29 to 30 during 2015–2019. Mexico is the only OECD-country having a mean average age of 28 or less.
  • The rate of first-time pregnancies in young women (under the age of 20) stands at just 11.8 births per 1,000, which is in correlation with the increasing mean age of first-time pregnancies (Source: OECD).
  • According to UNICEF, the average age of women at the birth of the first child in Canada has increased by ~1.5 years from 27.5 to 29 during 2005 to 2017.
  • In the Netherlands, the average age of first-time mothers increased from 29.4 years in 2013 to 29.9 years in 2019 (Source: CBS, 2019).

Restraint: Lesser precision of ovulation prediction kits

Ovulation prediction kits measure the luteinizing hormone (LH) surge that precedes about 24–36 hours prior to ovulation. These kits, however, cannot accurately confirm ovulation. In conditions such as luteinized unruptured follicle syndrome (in which a woman’s egg fails to emerge from its follicle after the LH surge occurs), ovulation predictors fail to give accurate results. Also, urinary LH measurement is only predictive of the onset of ovulation and cannot determine the date of ovulation or anovulation, thereby only indicating a very small period (of only about two days) of the fertile window.

Ovulation monitors can only test LH and do not identify other important ovulation signs, such as whether the cervical mucus is conductive for fertilization. Also, these monitors do not work when certain fertility drugs, such as Pergonal or the hormone hCG (Human Chorionic Gonadotropin), are present in the urine. Another major drawback of these kits is that they do not function for women in their 40s (specifically those approaching menopause) as they have increased levels of LH. These disadvantages of ovulation monitors limit their predictive capabilities and thus are restricting their adoption among end users.

Opportunity: Emerging nations to offer new growth avenues

Emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities to players operating in the fertility test market. The demand for fertility and ovulation monitors in emerging countries is expected to grow significantly in the coming years due to the rising infertility rates, increasing prevalence of PCOS and obesity, growing fertility education, and easy availability of fertility monitors through e-commerce websites, pharmacies, and retail shops/drugstores. In addition, friendly regulatory policies and less competition among players in developing markets (as compared to developed markets) have encouraged companies to focus on emerging countries.

Challenge: High cost of fertility testing monitors

Price and brand recognition are two important criteria for the adoption of fertility testing kits and monitors across the globe. Being elective and non-reimbursable in nature, the price of a device is a prime determinant for its use. Although advanced branded fertility monitors possess high accuracy in identifying the fertility window, they are priced at a premium due to the high costs involved in maintaining brand loyalty, obtaining regulatory approvals, and incorporating the software in the systems. Owing to the high cost of these fertility monitors, a very limited number of patients in developing countries can afford them. This, in turn, is limiting the acceptance of these products, mainly in developing countries.

Based on Purchase mode, OTC segment to register significant growth during the forecast period.

Based on the mode of purchase, the fertility test market is segmented into direct/prescription, OTC, and online products. In 2020 the OTC segment had the major market share and exibited high growth. The high growth of this segment is attributed to the inclination of patients towards self-monitoring of healthcare conditions, increasing initiatives by market players to spread awareness on fertility, and the rising preference for confidentiality and accessibility of test results.

Based on Application, the female fertility testing segment is expected to account for the largest share of the fertility test market in 2020

Based on the application, the fertility test  market is segmented into female fertility testing and male fertility testing. In 2020, the female fertility testing segment accounted for a larger market share, primarily due to the decreasing female fertility rates, availability of a wide range of fertility testing options for females, increase in gynecological issues in women (such as PCOD/PCOS), and the high cost of IVF procedures.

The ovulation prediction kits segment is expected to account for the largest share during the forecast period

Based on products, the fertility test market is segmented into ovulation prediction kits, fertility monitors & male fertility testing products.  Large share is attributed to ovulation prediction kits segment due to the increasing use of ovulation prediction kits, easy over-the-counter availability and low cost, and higher accuracy than natural fertility testing techniques, such as calendar methods and cervical mucus monitoring.

The home care settings segment is expected to register the highest CAGR during the forecast perio

Based on end-users, the fertility test market has been segmented based on end-user category—home care settings, hospitals and fertility clinics, and other end users. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.

North America dominated the global fertilty test market in 2020

North America, comprising the US and Canada, accounted for the largest share of the fertility test market in 2020. The large share of this region can primarily be attributed to factors such as high prevalence of infertility, increasing awareness about fertility testing among women, the rising age of first-time pregnancies in women, and the easy availability of ovulation and fertility monitors through e-commerce websites.

Fertility Test Market  by Region

Asia Pacific market is expected to grow at the highest CAGR during the forecast period.

Growth in the Asia Pacific market is majorly due to the growing number of women suffering from lifestyle disorders, increasing funding/investments toward the development of fertility and ovulation monitors, and the growing focus of both international and domestic players on the Asia Pacific fertility test market.

Key Market Players

Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), Sensiia (UK), and Mira Care (US), among others are some of the major players operating in the global fertility test market.

Scope of the report

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD million)

Segments covered

Products, Application, Mode of Purchase, End User and Region

Geographies covered

Europe, North America, the Asia Pacific, Latin America, and Middle East and Africa

Companies covered

Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), Sensiia (UK), and Mira Care (US), among others are some of the major players operating in the global fertility test market.

This report has segmented the fertility test market based on application, product, mode of purchase end user and region.

Global Fertility Test Market, by Application

  • Female Fertility Products
  • Male Fertility Products

Global Fertility Test Market, by Mode of Purchase

  • Direct/Prescription-based products
  • OTC-based products
  • Online Products

Global Fertility Test Market, by Product

  • Ovulation Prediction Kits
  • Fertility Monitors
  • Male Fertility Testing Products

Global Fertility Test Market, by End User

  • Home Care Settings
  • Hospitals and Fertility Clinics
  • Other End Users

Global Fertility Test Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East & Africa

 Recent Developments

February 2021, Fertility Focus partnered with ExSeed Health, a home-based sperm testing company. Under this partnership, both companies would together provide solutions to couples planning a pregnancy.

May 2019,  Fertility Focus (UK) launched an updated version of OvuSense App— OvuSense App v.2—with features such as increased flexibility in data viewing (three different ways), more choices for logging events than most of the apps, and increased accuracy in terms of monitoring cycles.

January 2017, NFI Consumer Healthcare (US), a division of Gregory Pharmaceutical Holdings (US), completed the acquisition of the e.p.t OTC pregnancy.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 25)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY USED FOR THE STUDY
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 28)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Indicative list of secondary sources
           2.1.2 PRIMARY DATA
           FIGURE 2 PRIMARY SOURCES
           FIGURE 3 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET ESTIMATION METHODOLOGY
           FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 PRODUCT-BASED MARKET ESTIMATION
           2.2.2 VOLUME-BASED MARKET ESTIMATION
           FIGURE 5 MARKET SIZE ESTIMATION: FERTILITY TEST MARKET
           FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 DATA TRIANGULATION
           FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 38)
           FIGURE 8 FERTILITY TEST MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
           FIGURE 9 FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2020 VS. 2025 (USD MILLION)
           FIGURE 10 FERTILITY TEST MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
           FIGURE 11 FERTILITY TEST MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
           FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE FERTILITY TEST MARKET

4 PREMIUM INSIGHTS (Page No. - 42)
    4.1 FERTILITY TEST MARKET OVERVIEW
           FIGURE 13 INCREASING FIRST-TIME PREGNANCY AGE TO DRIVE MARKET GROWTH
    4.2 FERTILITY TEST MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
           FIGURE 14 OVULATION PREDICTION KITS SEGMENT TO DOMINATE THE MARKET IN 2025
    4.3 APAC FERTILITY TEST MARKET SHARE, BY COUNTRY AND APPLICATION (2020)
           FIGURE 15 FEMALE FERTILITY TESTING SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC FERTILITY TEST MARKET IN 2020
    4.4 FERTILITY TEST MARKET SHARE, BY END USER, 2020 VS. 2025
           FIGURE 16 HOME CARE SETTINGS ARE THE LARGEST END USERS OF FERTILITY TESTING PRODUCTS
    4.5 FERTILITY TEST MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 17 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 47)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing first-time pregnancy age
                    5.2.1.2 Declining fertility rates across the globe
           FIGURE 19 DECLINE IN FERTILITY RATE IN THE US, 2008–2018
                    5.2.1.3 Growing population of women of reproductive age
                    5.2.1.4 Launch of advanced, easy-to-use fertility testing devices with high accuracy
                    5.2.1.5 Increasing awareness of fertility testing
                    5.2.1.6 Growing number of gynecological and reproductive issues in women and men
           5.2.2 RESTRAINTS
                    5.2.2.1 Lesser precision of ovulation prediction kits
                    5.2.2.2 Unproven accuracy of urine-based ovulation monitors in PCOS/PCOD patients
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emergence of combined kits for dual testing of pregnancy and ovulation
                    5.2.3.2 Emerging nations to offer new growth avenues
                    5.2.3.3 Online sales of fertility testing devices
                    5.2.3.4 High cost and low accuracy of IVF treatment
           TABLE 1 COST OF IVF ACROSS VARIOUS COUNTRIES
           5.2.4 CHALLENGES
                    5.2.4.1 High cost of fertility testing monitors
    5.3 ECOSYSTEM COVERAGE: PARENT MARKET (IN VITRO DIAGNOSTICS)
    5.4 REGULATORY ANALYSIS
           5.4.1 US
           TABLE 2 US FDA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
           FIGURE 20 US: REGULATORY PROCESS FOR IVD DEVICES
           5.4.2 CANADA
           TABLE 3 CANADA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
           FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
           5.4.3 EUROPE
           TABLE 4 EUROPE: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
           FIGURE 22 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
           5.4.4 JAPAN
           TABLE 5 CLASSIFICATION OF IVD REAGENTS IN JAPAN
           5.4.5 CHINA
           TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
           TABLE 7 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           5.4.6 INDIA
           FIGURE 23 INDIA: REGULATORY PROCESS FOR IVD DEVICES
    5.5 VALUE CHAIN ANALYSIS
    5.6 PRICING TREND ANALYSIS
           TABLE 8 AVERAGE PRICE OF FERTILITY TESTING PRODUCTS, BY COUNTRY, 2020 (USD)
    5.7 PORTER’S FIVE FORCES ANALYSIS
           5.7.1 OVERVIEW
           TABLE 9 FERTILITY TEST MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.7.2 THREAT OF NEW ENTRANTS
           FIGURE 24 THREAT OF NEW ENTRANTS
           5.7.3 THREAT OF SUBSTITUTES
           FIGURE 25 THREAT OF SUBSTITUTES
           5.7.4 BARGAINING POWER OF SUPPLIERS
           FIGURE 26 BARGAINING POWER OF SUPPLIERS
           5.7.5 BARGAINING POWER OF BUYERS
           FIGURE 27 BARGAINING POWER OF BUYERS
           5.7.6 DEGREE OF COMPETITION
           FIGURE 28 DEGREE OF COMPETITION
    5.8 NUMBER OF PATIENTS UTILIZING SPECIFIC FERTILITY TECHNIQUES WORLDWIDE (AS OF 2019)
           TABLE 10 NUMBER OF PATIENTS UTILIZING SPECIFIC FERTILITY TECHNIQUES WORLDWIDE (AS OF 2019)
    5.9 COVID-19 IMPACT

6 FERTILITY TEST MARKET, BY PRODUCT (Page No. - 69)
    6.1 INTRODUCTION
           TABLE 11 FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
    6.2 OVULATION PREDICTION KITS
           6.2.1 LOW COST AND EASY AVAILABILITY OF OVULATION PREDICTION KITS TO DRIVE THEIR ADOPTION
           TABLE 12 OVULATION PREDICTION KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 13 OVULATION PREDICTION KITS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 14 OVULATION PREDICTION KITS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 15 OVULATION PREDICTION KITS MARKET, BY END USER, 2018–2025 (USD MILLION)
    6.3 FERTILITY MONITORS
           TABLE 16 FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 17 FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 18 FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 19 FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 20 FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
           6.3.1 URINE-BASED FERTILITY MONITORS
                    6.3.1.1 Lower user-interpretation errors and fast and accurate results are advantages offered by urine-based monitors
           TABLE 21 URINE-BASED FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 22 URINE-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 23 URINE-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 24 URINE-BASED FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
           6.3.2 SALIVA-BASED FERTILITY MONITORS
                    6.3.2.1 Saliva-based monitors offer cost-effectiveness and better hygiene
           TABLE 25 SALIVA-BASED FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 26 SALIVA-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 27 SALIVA-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 28 SALIVA-BASED FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
           6.3.3 BLOOD-BASED FERTILITY MONITORS
                    6.3.3.1 Cost-effectiveness of blood-based monitors is expected to drive their adoption
           TABLE 29 BLOOD-BASED FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 30 BLOOD-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 31 BLOOD-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 32 BLOOD-BASED FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
           6.3.4 OTHER FERTILITY MONITORS
           TABLE 33 OTHER FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 34 OTHER FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 35 OTHER FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 36 OTHER FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
    6.4 MALE FERTILITY TESTING PRODUCTS
           6.4.1 MALE FERTILITY TESTING PRODUCTS TO ACCOUNT FOR THE LOWEST SHARE OF THE MARKET
           TABLE 37 MALE FERTILITY TESTING PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 38 MALE FERTILITY TESTING PRODUCTS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 39 MALE FERTILITY TESTING PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 40 MALE FERTILITY TESTING PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)

7 FERTILITY TEST MARKET, BY MODE OF PURCHASE (Page No. - 84)
    7.1 INTRODUCTION
           TABLE 41 FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
    7.2 DIRECT/PRESCRIPTION PRODUCTS
           7.2.1 AVAILABILITY OF INSURANCE COVERAGE FOR PRESCRIPTION REFILLS WILL DRIVE THE GROWTH OF THIS SEGMENT
           TABLE 42 DIRECT/PRESCRIPTION PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
    7.3 OTC PRODUCTS
           7.3.1 TREND OF SELF-MONITORING AND REMOTE ACCESS WILL BOOST THE GROWTH OF THIS SEGMENT
           TABLE 43 OTC PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
    7.4 ONLINE PRODUCTS
           7.4.1 INCREASING NUMBER OF E-PHARMACY PLATFORMS BOOSTING THE GROWTH OF THIS SEGMENT
           TABLE 44 ONLINE PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)

8 FERTILITY TEST MARKET, BY APPLICATION (Page No. - 89)
    8.1 INTRODUCTION
           TABLE 45 FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    8.2 FEMALE FERTILITY TESTING
           8.2.1 RISING PREVALENCE OF PCOD/PCOS WILL BOOST THE GROWTH OF THIS SEGMENT
           TABLE 46 GLOBAL BURDEN OF PCOS, 2019 (PER MILLION)
           TABLE 47 FERTILITY TEST MARKET FOR FEMALE FERTILITY TESTING APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
    8.3 MALE FERTILITY TESTING
           8.3.1 GROWING ADOPTION OF ADVANCED FERTILITY DEVICES TO AID THE GROWTH OF THIS SEGMENT
           TABLE 48 FERTILITY TEST MARKET FOR MALE FERTILITY TESTING APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)

9 FERTILITY TEST MARKET, BY END USER (Page No. - 94)
    9.1 INTRODUCTION
           TABLE 49 FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
    9.2 HOME CARE SETTINGS
           9.2.1 EASY ACCESS TO FERTILITY TESTING PRODUCTS THROUGH E-COMMERCE WEBSITES WILL STIMULATE THE GROWTH OF THIS SEGMENT
           TABLE 50 FERTILITY TEST MARKET FOR HOME CARE SETTINGS, BY REGION, 2018–2025 (USD MILLION)
    9.3 HOSPITALS AND FERTILITY CENTERS
           9.3.1 INCREASING NUMBER OF FERTILITY CENTERS TO BOOST THE GROWTH OF THIS SEGMENT
           TABLE 51 FERTILITY TEST MARKET FOR HOSPITALS AND FERTILITY CENTERS, BY REGION, 2018–2025 (USD MILLION)
    9.4 OTHER END USERS
           TABLE 52 FERTILITY TEST MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)

10 FERTILITY TEST MARKET, BY REGION (Page No. - 98)
     10.1 INTRODUCTION
           TABLE 53 FERTILITY TEST MARKET, BY REGION, 2018–2025 (USD MILLION)
     10.2 NORTH AMERICA
           FIGURE 29 NORTH AMERICA: FERTILITY TEST MARKET SNAPSHOT
           TABLE 54 NORTH AMERICA: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 55 NORTH AMERICA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 56 NORTH AMERICA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 57 NORTH AMERICA: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 58 NORTH AMERICA: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 59 NORTH AMERICA: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.2.1 US
                        10.2.1.1 High incidence of PCOD/PCOS will boost the growth of this market
           TABLE 60 US: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 61 US: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Decreasing fertility rate and the increasing mean age of first-time pregnancies driving the market
           TABLE 62 CANADA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 63 CANADA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
     10.3 EUROPE
           TABLE 64 EUROPE: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 65 EUROPE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 66 EUROPE: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 67 EUROPE: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 68 EUROPE: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 69 EUROPE: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Increasing fertility concerns and awareness to drive market growth in Germany
           TABLE 70 GERMANY: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 71 GERMANY: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Government initiatives and promotion of lab-based testing will stimulate market growth
           TABLE 72 UK: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 73 UK: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Increasing reforms for the management of POC tests to drive market growth in France
           TABLE 74 FRANCE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 75 FRANCE: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Decreasing fertility rates to drive the adoption of fertility testing devices in Italy
           TABLE 76 ITALY: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 77 ITALY: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Growing awareness of fertility testing products among women to drive market growth
           TABLE 78 SPAIN: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 79 SPAIN: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.3.6 REST OF EUROPE
           TABLE 80 ROE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 81 ROE: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
     10.4 ASIA PACIFIC
           FIGURE 30 ASIA PACIFIC: FERTILITY TEST MARKET SNAPSHOT
           TABLE 82 ASIA PACIFIC: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 83 ASIA PACIFIC: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 84 ASIA PACIFIC: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 85 ASIA PACIFIC: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 86 ASIA PACIFIC: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 87 ASIA PACIFIC: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Increasing average age of first-time pregnancies to drive market growth
           TABLE 88 JAPAN: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 89 JAPAN: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 China dominated the Asia Pacific fertility test market in 2020
           TABLE 90 CHINA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 91 CHINA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Increasing prevalence of PCOD/PCOS to drive market growth in India
           TABLE 92 INDIA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 93 INDIA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.4.4 AUSTRALIA
                        10.4.4.1 Supportive government initiatives and rising investments to drive market growth
           TABLE 94 AUSTRALIA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 95 AUSTRALIA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.4.5 SOUTH KOREA
                        10.4.5.1 Supportive government initiatives expected to positively impact market growth
           TABLE 96 SOUTH KOREA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 97 SOUTH KOREA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
           TABLE 98 ROAPAC: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 99 ROAPAC: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
     10.5 LATIN AMERICA
           TABLE 100 LATAM: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 101 LATAM: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 102 LATAM: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 103 LATAM: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 104 LATAM: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 105 LATAM: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Shrinking population concerns will drive market growth
           TABLE 106 BRAZIL: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 107 BRAZIL: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Increasing population to drive market growth in Mexico
           TABLE 108 MEXICO: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 109 MEXICO: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
           TABLE 110 ROLATAM: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 111 ROLATAM: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 UNFAVORABLE REIMBURSEMENT POLICIES ARE EXPECTED TO RESTRAIN MARKET GROWTH IN MEA
           TABLE 112 MEA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 113 MEA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 114 MEA: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
           TABLE 115 MEA: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 116 MEA: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 134)
     11.1 OVERVIEW
     11.2 KEY STRATEGIES
     11.3 GLOBAL MARKET SHARE ANALYSIS (2019)
           TABLE 117 FERTILITY TEST MARKET: DEGREE OF COMPETITION
           FIGURE 31 SWISS PRECISION DIAGNOSTICS HELD THE LEADING POSITION IN THE FERTILITY TEST MARKET IN 2020
     11.4 COMPETITIVE LEADERSHIP MAPPING
     11.5 VENDOR INCLUSION CRITERIA
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
           FIGURE 32 FERTILITY TEST MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
     11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2019)
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
           FIGURE 33 FERTILITY TEST MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 (SME/START-UPS)
     11.7 COMPANY PRODUCT FOOTPRINT ANALYSIS
           TABLE 118 PRODUCT FOOTPRINT OF COMPANIES
           TABLE 119 APPLICATION FOOTPRINT OF COMPANIES
           TABLE 120 REGIONAL FOOTPRINT OF COMPANIES
     11.8 COMPETITIVE SCENARIO
             11.8.1 PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
           TABLE 121 FERTILITY TEST MARKET: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS, 2017–2020
             11.8.2 EXPANSIONS
           TABLE 122 FERTILITY TEST MARKET: EXPANSIONS, 2017–2020
             11.8.3 OTHER STRATEGIES
           TABLE 123 FERTILITY TEST MARKET: OTHER STRATEGIES, 2017–2020

12 COMPANY PROFILES (Page No. - 146)
     12.1 KEY PLAYERS
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)* 
             12.1.1 SWISS PRECISION DIAGNOSTICS
           TABLE 124 SWISS PRECISION DIAGNOSTICS: BUSINESS OVERVIEW
           TABLE 125 SWISS PRECISION DIAGNOSTICS: PRODUCTS OFFERED
           TABLE 126 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2017 TO DECEMBER 2020
             12.1.2 CHURCH & DWIGHT
           TABLE 127 CHURCH & DWIGHT: BUSINESS OVERVIEW
           FIGURE 34 CHURCH & DWIGHT: COMPANY SNAPSHOT (2020)
           TABLE 128 CHURCH & DWIGHT: PRODUCTS OFFERED
             12.1.3 PRESTIGE BRANDS HOLDINGS
           TABLE 129 PRESTIGE BRANDS HOLDINGS: BUSINESS OVERVIEW
           TABLE 130 PRESTIGE BRANDS HOLDINGS: PRODUCTS OFFERED
           TABLE 131 FERTILITY TESTS MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
             12.1.4 BIOZHENA
           TABLE 132 BIOZHENA: BUSINESS OVERVIEW
           TABLE 133 BIOZHENA: PRODUCTS OFFERED
             12.1.5 FAIRHAVEN HEALTH
           TABLE 134 FAIRHAVEN HEALTH: BUSINESS OVERVIEW
           TABLE 135 FAIRHAVEN HEALTH: PRODUCTS OFFERED
             12.1.6 FERTILITY FOCUS
           TABLE 136 FERTILITY FOCUS: BUSINESS OVERVIEW
           TABLE 137 FERTILITY FOCUS: PRODUCTS OFFERED
           TABLE 138 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2016 TO DECEMBER 2020
           TABLE 139 FERTILITY TEST MARKET: DEALS, JANUARY 2016 TO DECEMBER 2020
             12.1.7 GERATHERM MEDICAL
           TABLE 140 GERATHERM MEDICAL: BUSINESS OVERVIEW
           FIGURE 35 GERATHERM MEDICAL: COMPANY SNAPSHOT (2019)
           TABLE 141 EXCHANGE RATES: EUR TO USD
           TABLE 142 GERATHERM MEDICAL: PRODUCTS OFFERED
             12.1.8 HILIN LIFE PRODUCTS
           TABLE 143 HILIN LIFE PRODUCTS: BUSINESS OVERVIEW
           TABLE 144 HILIN LIFE PRODUCTS: PRODUCTS OFFERED
             12.1.9 UEBE MEDICAL
           TABLE 145 UEBE MEDICAL: BUSINESS OVERVIEW
           TABLE 146 UEBE MEDICAL: PRODUCTS OFFERED
             12.1.10 ADVACARE PHARMA
           TABLE 147 ADVACARE PHARMA: BUSINESS OVERVIEW
           TABLE 148 ADVACARE PHARMA: PRODUCTS OFFERED
             12.1.11 AVA
           TABLE 149 AVA: BUSINESS OVERVIEW
           TABLE 150 AVA: PRODUCTS OFFERED
           TABLE 151 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2017 TO DECEMBER 2020
           TABLE 152 FERTILITY TEST MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
             12.1.12 BABYSTART (SNOWDEN HEALTHCARE)
           TABLE 153 BABYSTART: BUSINESS OVERVIEW
           TABLE 154 BABYSTART: PRODUCTS OFFERED
             12.1.13 VALLEY ELECTRONICS
           TABLE 155 VALLEY ELECTRONICS: BUSINESS OVERVIEW
           TABLE 156 VALLEY ELECTRONICS: PRODUCTS OFFERED
             12.1.14 SENSIIA
           TABLE 157 SENSIIA: BUSINESS OVERVIEW
           TABLE 158 SENSIIA: PRODUCTS OFFERED
           TABLE 159 FERTILITY TEST MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
             12.1.15 MIRA CARE
           TABLE 160 MIRA CARE: BUSINESS OVERVIEW
           TABLE 161 MIRA CARE: PRODUCTS OFFERED
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies. 
     12.2 OTHER COMPANIES
             12.2.1 EXSEED HEALTH
             12.2.2 TEMPDROP
             12.2.3 PREGMATE
             12.2.4 MEDICAL ELECTRONIC SYSTEMS
             12.2.5 SWIM COUNT (SUBSIDIARY OF MOTILTYCOUNT APS)

13 APPENDIX (Page No. - 174)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the fertility test market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Primary research was conducted after acquiring extensive knowledge about the global fertility test market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as hospitals, fertility clinics, research universities, academic institutions, and government institutions, among others) and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of business units, and senior managers) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. Approximately 30% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 70%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Fertility Test Market   Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

A detailed market estimation approach was followed to estimate and validate the size of the global fertility test market and other dependent submarkets.

  • The key players in the global fertility test market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights on the global fertility test market.
  • All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources.
  •  All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Fertility Test Market   Size, and Share

Data Triangulation:

After deriving the overall fertility test market value data from the market size estimation process, the total market value data was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various qualitative and quantitative variables as well as by analyzing regional trends for both the demand- and supply-side macroindicators.

Report Objectives:

  • To define, describe, and forecast the fertility test market based on product, application, mode of purchase, and end user
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall fertility test market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To estimate the size & growth potential of the market segments and subsegments with respect to five key regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa—and key countries
  • To profile the key players in the market and comprehensively analyze their global revenue shares and core competencies
  • To track and analyze competitive developments, such as product launches and approvals, partnerships, agreements, collaborations, and acquisitions in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the global fertility test market report:

Product analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company information

  • Detailed analysis and profiling of additional market players (up to five)

Geographic analysis

  • Further breakdown of the Rest of Europe fertility test market into Belgium, Austria, Denmark, Greece, Poland, and Russia, among other countries
  • Further breakdown of the Rest of Asia Pacific fertility test market into New Zealand, Vietnam, Philippines, Singapore, Malaysia, Thailand, and Indonesia, among other countries
  • Further breakdown of the Rest of Latin America fertility test market into Argentina and Colombia, among other countries
COVID-19

Get in-depth analysis of the COVID-19 impact on the Fertility Test Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Fertility Test Market

Request For Special Pricing
Report Code
MD 4215
Published ON
Apr, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Fertility Test Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home